The Geriatric Emergency Department Pharmacologic Harm Prevention Project

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
FallFall AccidentPoly PharmacyAdverse Drug EventsPharmacogenomic Drug InteractionPharmacogenomic Testing
Interventions
OTHER

DNA care pathway

"Pharmacogenomic test results will be transmitted to the participant's primary care physician to support medication optimization and prescribing decisions. Follow-up assessments will be conducted by telephone approximately 14 days after enrollment and then monthly for six months. These structured interviews will capture information on falls, fall-related injuries, medication changes, adverse drug effects, and new medical conditions.~Participants will also complete a monthly calendar to document medication changes, falls, and fall-related injuries. Medical records from the participant's primary care physician will be reviewed for corroborating information on falls, fall-related injuries, medication changes, medication-related side effects, and newly diagnosed medical problems."

Trial Locations (1)

33431

Florida Atlantic University, Boca Raton

All Listed Sponsors
lead

Florida Atlantic University

OTHER

NCT07216846 - The Geriatric Emergency Department Pharmacologic Harm Prevention Project | Biotech Hunter | Biotech Hunter